Providence Cancer Institute comparte actualizaciones sobre los avances en la atención de pacientes con melanoma

Providence Cancer Institute shares updates on advances in care for melanoma patients

In early October, Providence Cancer Institute of Oregon and AIM at Melanoma Foundation held a virtual patient education event for people with melanoma, plus their family and friends.

Watch full presentations here

Talks included: 

  • "Basics of Clinical Trials,” presented by Chris Fountain, RN, Clinician-Research, Providence Cancer Institute (video)

  • “Case Studies Illustrating Recent Advances in Medical Care,” presented by Brendan D. Curti, M.D., Medical Oncologist, Medical Director, Providence Melanoma Program, Providence Cancer Institute (video)

  • “New Treatments Under Development in Melanoma,” presented by Matthew H. Taylor, M.D., Medical Oncologist, Co-Medical Director, Providence Melanoma Program, Providence Cancer Institute (video)

  • “Communication with Family & Friends,” presented by Dawn Brucker, LCSW, OSW-C, Oncology Social Worker, Providence Cancer Institute (video)

We host a variety of classes, educational talks, and other events throughout the year. Learn more at providence.org.

Related news

Multi-indication clinical trials help evaluate new medications for future treatments

Studies will evaluate combination therapies for two types of melanoma

Melanoma studies: can adjuvant immunotherapy improve recurrence-free survival?

3/14/2023
New trials available at Earle A. Chiles Research Institute for patients with human epidermal growth factor receptor 2 positive (HER2+) colorectal cancer and patients with cholangiocarcinoma.
3/17/2023
In honor of Social Work Month we recognize the incredible contributions of oncology social workers.
2/15/2023
A new trial offered at Providence Cancer Institute is enrolling patients with early-stage HR-positive and HER2-negative breast cancer.
2/10/2023
As part of an international data-sharing consortium of leading cancer centers, Providence Cancer Institute and Swedish Cancer Institute work together to provide genomic data to Project GENIE.
Powered by Translations.com GlobalLink OneLink SoftwarePowered By OneLink